Evaluation of Maintaining Visual Performance in Participants Who Engage in Electronic Visual Tasking While Using Restasis®

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 21, 2015

Primary Completion Date

March 24, 2016

Study Completion Date

March 24, 2016

Conditions

Dry Eye Syndromes

Interventions

DRUG

Cyclosporine 0.05% Ophthalmic Emulsion

Cyclosporine 0.05% Ophthalmic Emulsion (RESTASIS®) 1 drop instilled in each eye twice a day.

Trial Locations (2)

Total Eye Care, PA, Memphis

Andover Eye Associates, Inc, Andover